Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MCRPC (metastatic Castration-resistant Prostate Cancer)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06155084
What this trial is testing

Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Hinova Pharmaceuticals Inc. 84
Large-scale testing (Phase 3)Study completedNCT02987543
What this trial is testing

Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
AstraZeneca 387
Testing effectiveness (Phase 2)UnknownNCT04926155
What this trial is testing

The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sun Yat-sen University 234
Not applicableStudy completedNCT04281147
What this trial is testing

Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body

Who this might be right for
Prostate Cancer
Bayer 4,301
Not applicableEnded earlyNCT05208229
What this trial is testing

The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 2
Early research (Phase 1)Looking for participantsNCT06943495
What this trial is testing

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Jean-Mathieu Beauregard 60
Not applicableWithdrawnNCT04742972
What this trial is testing

Prostate PMSABR Study

Who this might be right for
Prostate Cancer
Darren Poon
Large-scale testing (Phase 3)Looking for participantsNCT06925737
What this trial is testing

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Who this might be right for
Prostate CancerProstatic Neoplasms
Merck Sharp & Dohme LLC 1,440
Large-scale testing (Phase 3)Study completedNCT03834493
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 1,244
Early research (Phase 1)Ended earlyNCT05241613
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 28
Not applicableStudy completedNCT02269982
What this trial is testing

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

Who this might be right for
Prostate Cancer
Duke University 120
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Testing effectiveness (Phase 2)Study completedNCT03888612
What this trial is testing

Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Arvinas Inc. 248
Large-scale testing (Phase 3)WithdrawnNCT02053311
What this trial is testing

Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

Who this might be right for
Prostate Cancer
Swiss Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT04631601
What this trial is testing

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 55
Very early researchUnknownNCT04225910
What this trial is testing

Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 20
Early research (Phase 1)Study completedNCT02655822
What this trial is testing

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Who this might be right for
Renal Cell CancerMetastatic Castration Resistant Prostate Cancer
Corvus Pharmaceuticals, Inc. 502
Testing effectiveness (Phase 2)Looking for participantsNCT06100705
What this trial is testing

Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Yale University 26
Testing effectiveness (Phase 2)Looking for participantsNCT06267729
What this trial is testing

Study of AZD0754 in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 60
Testing effectiveness (Phase 2)Study completedNCT05655715
What this trial is testing

Checkpoint Inhibitors and SBRT for MCRPC

Who this might be right for
Prostate Cancer MetastaticCastrate Resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer+1 more
Herlev and Gentofte Hospital 90
Next Page